with copd - emrespiratory.co.uk€¦ · hardwick ccg - copd qof performance by practice - march...
TRANSCRIPT
COPD in Hardwick CCG Produced November 2015 by :
premature deaths due to respiratory disease in 201342
patients with COPD March 2015
estimated patients with COPD
estimated patients undiagnosed with COPD
NO flu vaccNO spirometry
(9.9%)
(80.0%)
(10.0%)
QOF performance - March 2015
3.01%
1.91%
3.06%
2.74%
NHS Hardwick CCG East Midlands
% COPD Prevalence - March 2015 Estimated % COPD prevalence1.41%
1.43%
1.64%
1.69%
1.75%
1.76%
1.83%
1.87%
1.89%
1.98%
2.07%
2.09%
2.09%
2.16%
2.24%
2.35%
2.51%
2.83%
3.01%
1.91%
0.00% 0.50% 1.00% 1.50% 2.00% 2.50% 3.00% 3.50%
NHS Rushcliffe CCG
NHS Leicester City CCG
NHS Nottingham City CCG
NHS East Leicestershire and Rutland CCG
NHS Nene CCG
NHS West Leicestershire CCG
NHS Southern Derbyshire CCG
NHS Nottingham North & East CCG
NHS South West Lincolnshire CCG
NHS South Lincolnshire CCG
NHS Nottingham West CCG
NHS Lincolnshire West CCG
NHS Newark & Sherwood CCG
NHS North Derbyshire CCG
NHS Erewash CCG
NHS Mansfield & Ashfield CCG
NHS Lincolnshire East CCG
NHS Corby CCG
NHS Hardwick CCG
East Midlands
% COPD Prevalence - March 2015
30.5
35.9
42
41.6
38.6
2009
2010
2011
2012
2013
Premature Mortality Rate from COPD/Respiratory 2009 - 2013
84change in COPD patients
on QOF registers between March 2014 & March 2015
Review with MRC dyspnoea scale
(77.9%)
(71.1%)
(81.4%)
Diagnosis confirmed by spirometry
FEV1 record
Flu immunisation
Estimate by ERPHO, 2011
Exceptions
(11.9%)
(13.7%)
(2.8%)
(10.2%)
(15.1%)
(15.8%)
ExceptionsNO FEV1
Exceptions
NO MRC dyspnoea scale
Exceptions
3,080 3,131 51
9697
773
368313
2,399
423
466
2,191
86488
2,506
Hardwick CCG - COPD QOF performance by Practice - March 2015
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
C810
50 T
HE V
ILLAG
E SU
RG
C810
55 N
ORT
H W
INGF
IELD
MED
CTR
C816
58 W
ELLB
ECK
DRIV
E SUR
G
C810
99 LI
MES
MED
CTR
C816
55 F
RIEN
DLY
FAM
ILY S
URG
C810
29 S
TAFF
A HE
ALTH
C810
08 B
LUE
DYKE
S SUR
G
C816
61 B
LACK
WEL
L MED
CTR
C810
33 S
HIRE
S HEA
LTHC
ARE
C810
95 E
MM
ETT
CARR
SUR
G
C810
56 C
LAY
CROS
S MED
CTR
C810
96 C
RAGS
HEA
LTH
CARE
C816
38 C
ASTL
E ST
REET
MED
CTR
C816
47 S
T LA
WRE
NCE
ROAD
SUR
G
C810
11 C
RESW
ELL &
LANG
WI
C816
33 G
RASS
MO
OR SU
RG
CCG
Aver
age
COPD diagnosis confirmed by spirometry
Exceptions %
No Spirometry %
Spirometry %
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
C816
58 W
ELLB
ECK
DRIV
E SUR
G
C816
61 B
LACK
WEL
L MED
CTR
C810
95 E
MM
ETT
CARR
SUR
G
C816
38 C
ASTL
E ST
REET
MED
CTR
C816
33 G
RASS
MO
OR SU
RG
C816
55 F
RIEN
DLY
FAM
ILY S
URG
C810
55 N
ORT
H W
INGF
IELD
MED
CTR
C810
50 T
HE V
ILLAG
E SU
RG
C810
33 S
HIRE
S HEA
LTHC
ARE
C810
29 S
TAFF
A HE
ALTH
C810
08 B
LUE
DYKE
S SUR
G
C810
99 LI
MES
MED
CTR
C816
47 S
T LA
WRE
NCE
ROAD
SUR
G
C810
96 C
RAGS
HEA
LTH
CARE
C810
56 C
LAY
CROS
S MED
CTR
C810
11 C
RESW
ELL &
LANG
WI
CCG
Aver
age
Had a review including an assessment of breathlessness using MRC dyspnoea scale in preceding 12 months
Exceptions %
No Review %
Review %
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
C810
55 N
ORT
H W
INGF
IELD
MED
CTR
C816
58 W
ELLB
ECK
DRIV
E SUR
G
C810
96 C
RAGS
HEA
LTH
CARE
C810
99 LI
MES
MED
CTR
C810
08 B
LUE
DYKE
S SUR
G
C810
95 E
MM
ETT
CARR
SUR
G
C816
61 B
LACK
WEL
L MED
CTR
C810
29 S
TAFF
A HE
ALTH
C810
11 C
RESW
ELL &
LANG
WI
C816
47 S
T LA
WRE
NCE
ROAD
SUR
G
C816
38 C
ASTL
E ST
REET
MED
CTR
C810
33 S
HIRE
S HEA
LTHC
ARE
C810
50 T
HE V
ILLAG
E SU
RG
C816
55 F
RIEN
DLY
FAM
ILY S
URG
C816
33 G
RASS
MO
OR SU
RG
C810
56 C
LAY
CROS
S MED
CTR
CCG
Aver
age
Influenza immunisation in the preceding 1 August to 31 March
Exceptions %
No Flu Immunisation %
Flu Immunisation %
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
C816
58 W
ELLB
ECK
DRIV
E SUR
G
C810
50 T
HE V
ILLAG
E SU
RG
C816
38 C
ASTL
E ST
REET
MED
CTR
C816
55 F
RIEN
DLY
FAM
ILY S
URG
C810
95 E
MM
ETT
CARR
SUR
G
C810
55 N
ORT
H W
INGF
IELD
MED
CTR
C816
33 G
RASS
MO
OR SU
RG
C810
33 S
HIRE
S HEA
LTHC
ARE
C810
29 S
TAFF
A HE
ALTH
C810
99 LI
MES
MED
CTR
C810
08 B
LUE
DYKE
S SUR
G
C816
61 B
LACK
WEL
L MED
CTR
C810
96 C
RAGS
HEA
LTH
CARE
C810
56 C
LAY
CROS
S MED
CTR
C810
11 C
RESW
ELL &
LANG
WI
C816
47 S
T LA
WRE
NCE
ROAD
SUR
G
CCG
Aver
age
A record of FEV1 in the preceding 12 months
Exceptions %
No FEV1 Record %
FEV1 Record %
Patients with a MRC Dyspnoea ≥ 3 in last 12 months with a record of oxygen saturation value 84.1 - 100.0% Practice Range
COPD Admissions - Hardwick CCG
% of admissions <=1 day LOS % of admissions <=2 days LOS death with a LoS <2 days in 2014-15
CCG
East Midlands average 50.6% 65.2% 1.5%
CCG Range 32.9% to 76.6% 44.7% to 82.1% 0% to 3.9%
COPD admissions (primary diagnosis)
2012-13 2013-14 2014-15
13.8%
10.7%
12.7%
% of readmissions within 30 days
2012-13 2013-14 2014-15
34.1%
24.9% 25.1%
% of readmissions within 90 days
2012-13 2013-14 2014-15
78.9 86.8
92.7 102.0 103.2 106.4 107.0
112.4 115.8 121.8 122.3 122.7 123.0 125.4 127.2 130.1 135.2
148.0 149.5
NHS
Not
tingh
am W
est C
CG
NHS
New
ark
& S
herw
ood
CCG
NHS
Ere
was
h CC
G
NHS
Sou
th W
est L
inco
lnsh
ire C
CG
NHS
Sou
th L
inco
lnsh
ire C
CG
NHS
Rus
hclif
fe C
CG
NHS
Lin
coln
shire
Wes
t CCG
NHS
Wes
t Lei
cest
ersh
ire C
CG
NHS
Man
sfie
ld &
Ash
field
CCG
NHS
Eas
t Lei
cest
ersh
ire a
nd R
utla
ndCC
G
NHS
Lin
coln
shire
Eas
t CCG
NHS
Har
dwic
k CC
G
NHS
Not
tingh
am N
orth
& E
ast C
CG
NHS
Sou
ther
n De
rbys
hire
CCG
NHS
Nor
th D
erby
shire
CCG
NHS
Cor
by C
CG
NHS
Nen
e CC
G
NHS
Lei
cest
er C
ity C
CG
NHS
Not
tingh
am C
ity C
CG
COPD admission rate per 1,000 COPD population (12 months to March 2015)
CCG East Midlands
184
37
15 8 6 2
1 2 3 4 5 6 plus
Frequency of COPD admissions per patient in 12 months to March 2015
52.3% 67.4%
Average length of stay = East Midlands = 5.9CCG Range = 4.8 – 7.3
patients had only 1 admission
0.0%
384289 378
5.7 days
184
Hardwick CCG – COPD – Smoking, Oxygen and Prescribing data
Developed by London Respiratory Network and London School of Economics the pyramid of value gives estimates ofcost per quality adjusted life year gained for COPD interventions
QALY = quality adjusted life years
No current evidence for Telemonitoring
Use GRASP COPD or ask your prescribing adviser.
Pyramid of value for COPD interventions
Telehealth for chronic disease
£92,000/QALY
Triple Therapy £7,000 -
£187,000/QALY
LABA £8,000/QALY
Tiotropium £7,000/QALY
Pulmonary Rehabilitation £2,000 - 8,000/QALY
Stop Smoking Support with pharmacotherapy £2,000/QALY
Flu vaccination £1,000/QALY in “at risk” population
Reference : Zaid Zoumot et al. Thorax doi: 10.1136/thoraxjnl-2014-205667
National COPD Audit of Pulmonary Rehabilitation - Organisational Audit, November 2015
Smoking & smoking cessation data by Local Authority
Number of patients NOT receivedinfluenza immunisation
Inhaled corticosteroids accounts for 8% of total prescribing spend in East Midlands in 2014-15
02 £1,4
99
£1,5
72
£1,6
12
£1,6
51
£1,7
08
£1,7
11
£1,7
68
£1,7
73
£1,8
25
£1,8
80
£1,8
81
£1,8
87
£1,8
94
£1,9
24
£1,9
73
£1,9
74 £2
,128
£2,1
70
£2,2
76
£1,8
48
£0
£500
£1,000
£1,500
£2,000
£2,500
Inhaled corticosteroid - Net Ingredient Cost (NIC) 2014-15 per STAR-PU
Smoking data by Local Authority
Oxygen for patients with COPD - October 2014 to Sept 2015
Inhaled corticosteroid Expenditure 2014-15
£1,256,595
Inhaled corticosteroid NIC 2014-15 per STAR-PU
£1,708£26.76
87
28.08
£82,417
EnglandSmoking Prevalence in adults - current smokers (2014)
Better Similar
18.0%
28.0%
2,829
Worse
Smoking Prevalence in adults in routine and manual occupations - current smokers (2014)
Successful quitters at 4 weeks per 100,000 smokers (2014-15)
Derbyshire
19.9%
31.5%
1,559
compared to England average
31.08